Ostrovok.ru Raises US$25 Million from Investment Consortium (CEE and CIS)

Global venture capital firm General Catalyst Partners has led a US$25 million investment in Russian online travel services company Ostrovok.ru. The company intends to use the investment to fund the development of new and existing products, including a service to book hotels on partner websites. Additional participants in the… Read More

Navis Invests in Strateq Group (Asia)

Asia-focused private equity firm Navis Capital Partners has invested in Malaysian information technology services company Strateq. Navis, alongside the Strateq management team, purchased a 54.8 percent stake from Malaysian investment firm Kencana Capital Assets and also invested new growth capital into the company. Financial details of the transaction were… Read More

Moller y Pérez-Cotapos Raises US$92 Million in IPO (Latin America)

Moller y Pérez-Cotapos (MPC), a Chilean construction company backed by international private equity investor CVCI Private Equity, has raised approximately US$92 million through an initial public offering on the Santiago Stock Exchange. The offering totaled 105 million shares, including a primary offer from MPC and a secondary offering of… Read More

Mediterra Capital Raises EUR164 Million Private Equity Fund for Turkey (CEE and CIS)

Turkey-focused private equity firm Mediterra Capital has confirmed the final closing of its first private equity fund, Mediterra Capital Partners I, with EUR164 million (approximately US$213 million) in commitments. The fund raised capital from institutional investors including development finance institutions, funds of funds and asset management companies, as well… Read More

ChrysCapital Acquires Stake in Ipca Laboratories for US$40 Million (Asia)

India-focused investment firm ChrysCapital has invested approximately US$40 million for a 4 percent stake in Indian pharmaceuticals manufacturer Ipca Laboratories. The investment was reportedly made through incremental share purchases on the Bombay Stock Exchange over the past 5 to 6 months. Ipca Laboratories manufactures drugs for domestic and international… Read More

Shoreline Capital Announces Fund II Closed Over US$300 Million (Asia)

China-focused distressed debt and special situations investment firm Shoreline Capital Management has announced the closing of its second fund, Shoreline China Value II, with US$303 million in commitments. The firm raised capital from institutional investors in North America, Europe, Asia and the Middle East. The fund has already invested… Read More

Matahari Share Sale Valued at US$1.3 Billion (Asia)

Global private equity and investment advisory firm CVC Capital Partners and Indonesian investment holding company PT Multipolar Tbk have sold nearly half of their stake in Indonesian retailer Matahari Department Store for approximately US$1.3 billion. CVC and Multipolar reportedly sold around 1.17 billion shares in the Indonesia Stock Exchange-listed… Read More



(default archive template)